View in EDS HTML Full Text PDF Full Text

TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis.

Saved in:
Bibliographic Details
Title: TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis.
Authors: Chen L; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Lin W; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Zhang H; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Geng S; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Le Z; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Wan F; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Huang Q; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Chen H; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Liu X; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Lu JJ; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China., Kong L; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China. konglinjiang@163.com.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China. konglinjiang@163.com.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China. konglinjiang@163.com.
Source: Cell death & disease [Cell Death Dis] 2024 Mar 01; Vol. 15 (3), pp. 178. Date of Electronic Publication: 2024 Mar 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38429254
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.<br /><searchLink fieldCode="AU" term="%22Lin+W%22">Lin W</searchLink>; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.<br /><searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.<br /><searchLink fieldCode="AU" term="%22Geng+S%22">Geng S</searchLink>; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.<br /><searchLink fieldCode="AU" term="%22Le+Z%22">Le Z</searchLink>; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.<br /><searchLink fieldCode="AU" term="%22Wan+F%22">Wan F</searchLink>; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.<br /><searchLink fieldCode="AU" term="%22Huang+Q%22">Huang Q</searchLink>; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.<br /><searchLink fieldCode="AU" term="%22Chen+H%22">Chen H</searchLink>; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.<br /><searchLink fieldCode="AU" term="%22Lu+JJ%22">Lu JJ</searchLink>; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.<br /><searchLink fieldCode="AU" term="%22Kong+L%22">Kong L</searchLink>; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China. konglinjiang@163.com.; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, 201321, China. konglinjiang@163.com.; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China. konglinjiang@163.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101524092%22">Cell death & disease</searchLink> [Cell Death Dis] 2024 Mar 01; Vol. 15 (3), pp. 178. <i>Date of Electronic Publication: </i>2024 Mar 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101524092 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-4889 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Death Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38429254
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41419-024-06472-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 178
    Titles:
      – TitleFull: TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chen L
      – PersonEntity:
          Name:
            NameFull: Lin W
      – PersonEntity:
          Name:
            NameFull: Zhang H
      – PersonEntity:
          Name:
            NameFull: Geng S
      – PersonEntity:
          Name:
            NameFull: Le Z
      – PersonEntity:
          Name:
            NameFull: Wan F
      – PersonEntity:
          Name:
            NameFull: Huang Q
      – PersonEntity:
          Name:
            NameFull: Chen H
      – PersonEntity:
          Name:
            NameFull: Liu X
      – PersonEntity:
          Name:
            NameFull: Lu JJ
      – PersonEntity:
          Name:
            NameFull: Kong L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2024 Mar 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2041-4889
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Cell death & disease
              Type: main
ResultId 1